CompuGroup Medical Financials
| CMPVF Stock | USD 18.04 0.00 0.00% |
CompuGroup |
Understanding current and past CompuGroup Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CompuGroup Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in CompuGroup Medical's assets may result in an increase in income on the income statement.
CompuGroup Medical Stock Summary
CompuGroup Medical competes with Legacy Education, Apple, NVIDIA, Microsoft, and Amazon. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugoup Med is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Maria Trost 21, |
| Benchmark | Dow Jones Industrial |
| Website | www.cgm.com |
| Phone | 49 261 8000 0 |
| Currency | USD - US Dollar |
CompuGroup Medical Key Financial Ratios
There are many critical financial ratios that CompuGroup Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CompuGroup Medical reports annually and quarterly.| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Beta | 1.07 | |||
| Z Score | 2.4 |
CompuGroup Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CompuGroup Medical's current stock value. Our valuation model uses many indicators to compare CompuGroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CompuGroup Medical competition to find correlations between indicators driving CompuGroup Medical's intrinsic value. More Info.CompuGroup Medical SE is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CompuGroup Medical SE is roughly 3.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CompuGroup Medical's earnings, one of the primary drivers of an investment's value.CompuGroup Medical Systematic Risk
CompuGroup Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CompuGroup Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on CompuGroup Medical correlated with the market. If Beta is less than 0 CompuGroup Medical generally moves in the opposite direction as compared to the market. If CompuGroup Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CompuGroup Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CompuGroup Medical is generally in the same direction as the market. If Beta > 1 CompuGroup Medical moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for CompuGroup Pink Sheet analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |